VirnetX sets up up to $19.1 million stock sale program with Titan Partners
On October 1, 2026, VirnetX entered into an at-the-market offering agreement with Titan Partners Securities LLC as sales agent, under which it may sell up to $19,135,717 of common stock from time to time. The company is not obligated to sell any shares, and it intends to use any net proceeds for product development, marketing and general corporate purposes.
Key points
- Sales agreement dated October 1, 2026 covers up to $19,135,717 of common stock, sold through Titan Partners Securities LLC.
- The company will pay the agent a commission of 3.0% of the gross sales price of shares sold.
- Shares are offered under a Form S-3 shelf registration (File No. 333-295960) and a prospectus supplement dated October 1, 2026.
- Proceeds, if any, are intended for product development, marketing and general corporate purposes.
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.